Literature DB >> 11110710

An adherent condition is required for formation of multinuclear osteoclasts in the presence of macrophage colony-stimulating factor and receptor activator of nuclear factor kappa B ligand.

T Miyamoto1, F Arai, O Ohneda, K Takagi, D M Anderson, T Suda.   

Abstract

Identification of receptor activator of nuclear factor-kappaB (RANK) and RANK-ligand (RANKL) has provided new insights into the osteoclast differentiation pathway. Osteoclast precursor cells were isolated using monoclonal antibodies against c-Fms and RANK, and the effect of adherence on the in vitro differentiation and proliferation of these cells was examined in 2 different types of stromal-cell-free culture systems: a semisolid culture medium (a nonadherent system) and a liquid culture medium (an adherent system). Osteoclast precursor cells were not able to differentiate into mature osteoclasts efficiently in the semisolid culture system. Trimerized RANKL enhanced osteoclast differentiation in semisolid cultures, but not to the extent seen when cells were allowed to adhere to plastic. Initial precursor cells were capable of differentiating into macrophages or osteoclasts. Once these cells were transferred to adherent conditions, striking differentiation was induced. Multinuclear cells were observed even after they had displayed phagocytic activity, which suggests that cell adhesion plays an important role in the differentiation of osteoclast precursor cells. Integrins, especially the arginine-glycine-aspartic acid (RGD)-recognizing integrins alpha(v) and beta(3), were needed for osteoclast-committed precursor cells to proliferate in order to form multinuclear osteoclasts, and the increase in cell density affected the formation of multinuclear cells. A model of osteoclast differentiation with 2 stages of precursor development is proposed: (1) a first stage, in which precursor cells are bipotential and capable of anchorage-independent growth, and (2) a second stage, in which the further proliferation and differentiation of osteoclast-committed precursor cells is anchorage-dependent. (Blood. 2000;96:4335-4343)

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11110710

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  33 in total

1.  HIF1α is required for osteoclast activation by estrogen deficiency in postmenopausal osteoporosis.

Authors:  Yoshiteru Miyauchi; Yuiko Sato; Tami Kobayashi; Shigeyuki Yoshida; Tomoaki Mori; Hiroya Kanagawa; Eri Katsuyama; Atsuhiro Fujie; Wu Hao; Kana Miyamoto; Toshimi Tando; Hideo Morioka; Morio Matsumoto; Pierre Chambon; Randall S Johnson; Shigeaki Kato; Yoshiaki Toyama; Takeshi Miyamoto
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-10       Impact factor: 11.205

Review 2.  Role of osteoclasts in regulating hematopoietic stem and progenitor cells.

Authors:  Takeshi Miyamoto
Journal:  World J Orthop       Date:  2013-10-18

Review 3.  Osteoimmunology: interactions of the bone and immune system.

Authors:  Joseph Lorenzo; Mark Horowitz; Yongwon Choi
Journal:  Endocr Rev       Date:  2008-05-01       Impact factor: 19.871

4.  LPS administration increases CD11b+ c-Fms+ CD14+ cell population that possesses osteoclast differentiation potential in mice.

Authors:  Takuya Enomoto; Masamichi Takami; Matsuo Yamamoto; Ryutaro Kamijo
Journal:  Cytotechnology       Date:  2017-04-20       Impact factor: 2.058

5.  Osteoprotegerin expressed by osteoclasts: an autoregulator of osteoclastogenesis.

Authors:  J H Kang; H M Ko; J S Moon; H I Yoo; J Y Jung; M S Kim; J T Koh; W J Kim; S H Kim
Journal:  J Dent Res       Date:  2014-09-25       Impact factor: 6.116

6.  Interleukin-1 receptor-associated kinase-4 (IRAK4) promotes inflammatory osteolysis by activating osteoclasts and inhibiting formation of foreign body giant cells.

Authors:  Eri Katsuyama; Hiroya Miyamoto; Tami Kobayashi; Yuiko Sato; Wu Hao; Hiroya Kanagawa; Atsuhiro Fujie; Toshimi Tando; Ryuichi Watanabe; Mayu Morita; Kana Miyamoto; Yasuo Niki; Hideo Morioka; Morio Matsumoto; Yoshiaki Toyama; Takeshi Miyamoto
Journal:  J Biol Chem       Date:  2014-11-17       Impact factor: 5.157

Review 7.  Role of RANKL in cancer development and metastasis.

Authors:  Kazuo Okamoto
Journal:  J Bone Miner Metab       Date:  2021-01-02       Impact factor: 2.626

8.  Essential role of the cryptic epitope SLAYGLR within osteopontin in a murine model of rheumatoid arthritis.

Authors:  Nobuchika Yamamoto; Fumihiko Sakai; Shigeyuki Kon; Junko Morimoto; Chiemi Kimura; Harumi Yamazaki; Ikuko Okazaki; Nobuo Seki; Takashi Fujii; Toshimitsu Uede
Journal:  J Clin Invest       Date:  2003-07       Impact factor: 14.808

9.  The Blimp1-Bcl6 axis is critical to regulate osteoclast differentiation and bone homeostasis.

Authors:  Yoshiteru Miyauchi; Ken Ninomiya; Hiroya Miyamoto; Akemi Sakamoto; Ryotaro Iwasaki; Hiroko Hoshi; Kana Miyamoto; Wu Hao; Shigeyuki Yoshida; Hideo Morioka; Kazuhiro Chiba; Shigeaki Kato; Takeshi Tokuhisa; Mitinori Saitou; Yoshiaki Toyama; Toshio Suda; Takeshi Miyamoto
Journal:  J Exp Med       Date:  2010-04-05       Impact factor: 14.307

Review 10.  Osteoclasts and the immune system.

Authors:  Tomoki Nakashima; Hiroshi Takayanagi
Journal:  J Bone Miner Metab       Date:  2009-05-20       Impact factor: 2.626

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.